Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation

NCT06357819 is registered in ClinicalTrials.gov with bioLytical Laboratories as lead sponsor.

NCT NCT06357819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06357819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation
Lead sponsor
bioLytical Laboratories
Phase
Observational
Overall status
Completed
Start date
October 12, 2023
Completion date
December 17, 2023
Enrollment
405 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c